tiprankstipranks
Trending News
More News >
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market

Compare Diamedica Therapeutics (DMAC) vs. Competitors

Compare
568 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Diamedica Therapeutics
$7.42
$394.49M
-10.34
29.95%
5 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$4.63
$42.87M
-0.47
-66.81%
2 Buy
3 Hold
0 Sell
Moderate Buy
Capricor Therapeutics
$24.20
$1.32B
-13.45
76.64%
8 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.64
$393.93M
-1.62
-64.69%
6 Buy
3 Hold
1 Sell
Moderate Buy
Benitec Biopharma
$11.63
$395.51M
-11.57
12.91%
3 Buy
0 Hold
0 Sell
Strong Buy
Annexon Biosciences
$6.16
$878.50M
-4.38
46.67%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DMAC
Diamedica Therapeutics
7.42
1.39
23.05%
TVRD
Tvardi Therapeutics
4.63
-9.71
-67.71%
CAPR
Capricor Therapeutics
24.20
9.30
62.42%
RCKT
Rocket Pharmaceuticals
3.64
-6.84
-65.27%
BNTC
Benitec Biopharma
11.63
0.94
8.79%
ANNX
Annexon Biosciences
6.16
2.01
48.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts